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The voltage-dependent anion-selective channel (VDAC) is an intrinsic b-barrel membrane protein located
within the mitochondrial outer membrane where it serves as a pore, connecting the mitochondria to the
cytosol. The high-resolution structures of both the human and murine VDACs have been resolved by X-
ray diffraction and nuclear magnetic resonance spectroscopy (NMR) in 2008. However, the structural
data are not completely in line with the ﬁndings that were obtained after decades of research on
biochemical and functional analysis of VDAC. This discrepancy may be related to the fact that structural
biology studies of membrane proteins reveal speciﬁc static conformations that may not necessarily
represent the physiological state. For example, overexpression of membrane proteins in bacterial in-
clusion bodies or simply the extraction from the native lipid environment using harsh puriﬁcation
methods (i.e. chaotropic agents) can disturb the physiological conformations and the supramolecular
assemblies. To address these potential issues, we have developed a method, allowing rapid one step
puriﬁcation of endogenous VDAC expressed in the native mitochondrial membrane without over-
expression of recombinant protein or usage of harsh chaotropic extraction procedures. Using the
Saccharomyces cerevisiae isoform 1 of VDAC as a model, this method yields efﬁcient puriﬁcation, pre-
serving VDAC in a more physiological, native state following extraction from mitochondria. Single par-
ticle analysis using transmission electron microscopy (TEM) demonstrated conservation of oligomeric
assembly after puriﬁcation. Maintenance of the native state was evaluated using functional assessment
that involves an ATP-binding assay by micro-scale thermophoresis (MST). Using this approach, we were
able to determine for the ﬁrst time the apparent KD for ATP of 1.2 mM.
© 2016 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The voltage-dependent anion channel (VDAC) is an outer
mitochondrial membrane (OMM) protein present in plant, fungi
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r B.V. This is an open access articleexpressed. Initially described as a molecular ﬁlter similar to bac-
terial porins, VDAC is now recognized as being a fairly selective
channel. VDAC serves as the communication link between the
mitochondrial matrix and the cytosolic environment by controlling
the constituents of the mitochondrial inter-membrane space.
While VDAC can be permeable to molecules under 5 kDa, which
includes most cellular ions and vital metabolites (succinate, citrate,
NADH, ATP, etc.), there is strong evidence of direct substrate
binding and selective transport. Of particular relevance are the
nucleotide binding sites (NBS) and the ability to transport ATP
generated by the mitochondria. Thus, VDAC, in tandem with the
selective inner mitochondrial ADP/ATP carrier, can serve as a
regulated supply gate for energy delivery throughout the cell. The
direct binding and transport of ATP to VDACwas ﬁrst demonstrated
through binding studies on ATP agarose columns and later
conﬁrmed using radiolabeled and photo-activated cross-linking
studies using nucleotide analogues [1]. The puriﬁcation methodunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Gincel [2] where hydroxyapatite (HA) chromatography was
employed to extract the ADP/ATP carrier and VDAC from isolated
mitochondria. In order to remove the large portion of the ADP/ATP
carrier present in the eluted fraction, the HA was combined with
Celite chromatography. A second step of puriﬁcation was then
performed using a reactive red-agarose (RRA) column to concen-
trate the protein content and to exchange the detergent.
VDAC activity is mediated by interactions with various proteins
such as hexokinase, ADP/ATP carrier, mitochondrial creatine kinase
(MtCK), pro-apoptotic proteins belonging to the BCL2 family,
tubulin and also the IP3 receptor [3]. It plays an important role in
the metabolism and apoptosis of eukaryotic cells and it was
recently proposed to be a therapeutic target for the treatment of
Alzheimer's disease [4], diabetes [5] and, most promisingly, cancer
[6].
Following the discovery of mitochondrial VDAC nearly forty
years ago by Mannella and Bronner [7], the structure and mem-
brane topology has been the subject of active debate and contro-
versy in spite of the 2008 publications of three independent high-
resolution 3D structures of mammalian homologues [8e10]. The
structures revealed a b-barrel pore containing 19 anti-parallel b-
strands. The reported structural ﬁndings sharply contrast the in-
formation gathered after decades of intense biochemical analysis,
probing the functional organization of the protein. Interestingly,
the ﬂexible N-terminal domain of about 20 amino acids is located
inside the pore in all three published structures, while previous
topological analysis demonstrated 13 b-strands with the N-termi-
nal domain residing within the bilayer [11].
In these three above mentioned structural studies, human or
mouse VDAC were overexpressed in E. coli. Solubilization from in-
clusion bodies and subsequent refolding were mandatory steps
prior to puriﬁcation, leading to potential complications and un-
natural conformations. The difﬁculty in producing a physiologically
relevant VDAC in an exogenous environment has been demon-
strated using the puriﬁed protein in functional assays. According to
Colombini, only a fraction of the puriﬁed VDAC in Triton X-100
micelles was functional after reconstitution in cholesterol loaded
artiﬁcial liposomes. In this particular condition, following their
puriﬁcation procedure, the presence of sterol lipids seems to be
essential to recover functional protein. Such a protein-detergent-
lipid complex was not suitable for crystallization by vapor diffu-
sion methods employed for VDAC during the determination of the
three published structures. Thus, Colombini argued that the protein
used for crystallization was not in a functional conﬁguration. This
highlights the important role of lipid molecules, particularly
cholesterol and analogues, in the structure determination of VDAC
and their need to keep the protein within its native environment.
Moreover, the topology of the high-resolution structures has not
yet been fully correlated with previous surface accessibly data such
as protease treatment, peptide-speciﬁc antibodies and FLAG la-
beling [12e14]. Also, the overwhelming incongruity between
functional biochemical and structural data has led many, including
Colombini, to propose that the 3D structures correspond to a non-
functional states of VDAC [11].
In response to Colombini's critique [11], the authors of the 3D
structural work of VDAC argued as follows: Prior to structure
determination, different models were proposed for VDAC on the
basis of biochemical, biophysical and computational approaches,
with drastic variations in overall topology, containing 12 to 16 b-
strands [15]. On the other hand, the recently resolved mammalian
structures consistently revealed 19 b-strands in three independent
investigations, using two distinct structural technologies, X-ray
crystallography and nuclear magnetic resonance spectroscopy.
Also, these authors note, that all three structures showed residueE73 to be oriented toward the hydrophobic membrane environ-
ment, as originally suggested by De Pinto et al. by who determined
the speciﬁc interaction of this residue with the highly hydrophobic
compound dicyclohexylcarbodiimide (DCCD) [16]. The structural
investigations furthermore point out that the refolding technique
has been validated extensively and that, from 60,000 structures
deposited in RCSB Protein Data Bank, at least 1000 were structur-
ally solved following proper refolding. To this end, it should be
noted, however, that only about 2.5% of these are integral mem-
brane proteins which potentially weakens this argument. Then,
looking at previous TEM and AFM images, these authors further-
more indicate that the dimension of the pore of the new 3D-
structures of 3.4e3.8 nm is similar to that revealed by those images.
However, numerous studies revealed smaller pore-sizes of
1.3e2.5 nm. Thus, in spite of all these arguments in favor of the 3D
structures, there are still important questions to be addressed with
regard to the size of the pore and the real number of b-strands, the
localization of the N-terminus and, as highlighted below, the native
conformation of VDAC used for structural determination.
Beyond the structure of the individual subunits, the VDAC su-
pramolecular assembly has been demonstrated by atomic force
microscopy (AFM) from freshly isolated OMMs. The results
revealed the existence of monomers to tetramers, hexamers and
higher oligomers, based on experiments without chemical modi-
ﬁcation or detergent solubilization [17]. Previous studies focused
on the structural organization of VDAC based on observations from
isolated VDAC protein from different sources after cross-linking
[18,19]. Interestingly, the group of Mannella showed, based on
low-dose electron microscopy images analysis from 2D-crystal of
VDAC, a unit cell composed of six channels [20]. Moreover, the
oligomerization of VDAC into the unit cell seems to be regulated.
Indeed, VDAC oligomerization is involved in the release of pro-
apototic factors such as cytochrome c from mitochondria,
inducing subsequent apoptosis [21].
Given the above statements, our aimwas to develop an efﬁcient
protocol to isolate non-recombinant VDAC in a conserved native
form for subsequent physiological and structural evaluation.
In general, membrane protein (MP) puriﬁcation represents a
major challenge in protein biochemistry. MPs usually exist at low
concentrations in biological membranes and hence they need to be
overexpressed in a heterologous system. VDAC, on the contrary, is
naturally highly expressed in the OMM and it can easily be isolated
from yeast mitochondria. Starting with isolated mitochondria is an
advantage in order to maintain VDAC in its native lipid environ-
ment as much as possible prior to puriﬁcation. Therefore, we
developed a VDAC puriﬁcation procedure, allowing us to obtain
pure and functional non-recombinant VDAC1 directly from isolated
yeast mitochondria. This avoids the risky and cumbersome step of
protein re-naturation after solubilization from inclusion bodies that
is necessary when human or mouse VDAC is over-expressed in E.
coli.
Saccharomyces cerevisiae VDAC1 (ScVDAC1) corresponds to iso-
form 1 of the two existing isoforms in yeast. It shares 58% similarity
with the human VDAC and 71% with the mouse homologue [13],
suggesting that the results obtained with the yeast protein will be
highly correlative to the human orthologue. In our study, we suc-
cessfully puriﬁed, using a one-step protocol, ScVDAC1 in non-
denaturing conditions, using HECAMEG® as detergent. Then we
determined the oligomeric structure of solubilized proteins
reﬂecting its native functional state, by negative staining trans-
mission electron microscopy. HECAMEG® is non-ionic, glucose
based very mild detergent for membrane protein puriﬁcation
known to be suitable for structural biology approaches. Following
this simple and fast method, we present structural data at low
resolution of isolated ScVDAC1 and discuss the supra-molecular
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To assess the integrity and functional state of the puriﬁed
ScVDAC1 protein, micro-scale thermophoresis (MST) of solubilized
ScVDAC1 was performed measuring binding to ATP.
2. Material and methods
2.1. Chemicals and immunochemical reagents
Hydroxyapatite (HA) chromatography was purchased from Bio-
Rad (Biogel #130-0420, Hercules, CA, USA). The detergents octyl
tetraethylene glycol ether (Anapoe-C8E4), polyoxyethylene (6)
decyl ether (Anapoe-C10E6), 3-Laurylamido-N,N0-dimethylpropyl
amine oxide (LAPAO), a-[4-(1,1,3,3-tetramethylbutyl)phenyl]-u-
hydroxy-poly(oxy-1,2-ethanediyl) (Triton X-100) were purchased
from Affymetrix® (St. Clara, CA, USA) and 6-O-(N-heptylcarba-
moyl)-methyl-b-D-gluco-pyranoside (HECAMEG®) from VEGATEC
SARL (Rungis, France). Bovine serum albumin (BSA) was from
Sigma-Aldrich® (St. Louis, MO, USA). Rabbit polyclonal antibodies
against yeast SDS-treated ScVDAC1 were provided by Guy Lauquin
(IBGC, Bordeaux, France).
2.2. Bacterial and yeast strains, media
Strains were cultivated and transformed as previously described
[22]. A full description of the compositions of all media used,
including YPL (lactate-containing richmedium), can be found in the
same article. The E. coli strain used for plasmid propagation was
DH5a (Invitrogen) (F- 480dlacZDM15 D(lacZYA-argF) U169 recA1
endA1 hsdR17(rk-,mkþ) phoA supE44 l-thi-1 gyrA96 relA1). The
yeast strain used in this study was W303 (MATa{leu2-3112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15}), provided by Patrice Catty
(CEA, Grenoble, France).
2.3. Large scale growth
Large-scale growth ofW303was performed using a Scientiﬁc FS
305 fermenter from New Brunswick (the cylindrical glass reactor
having a 12-l culture volume capacity). The dissolved oxygen level
in the YPL medium was regulated by sterile air pressure. The
fermenter was inoculated by diluting a saturated culture (1:60) in
growthmedium. It was subsequently agitated at 300 rpm in awater
bath at 30 C. Antifoam agent was previously added to avoid
emulsion.
2.4. Isolation of mitochondria
The protocol for mitochondria isolationwas adapted fromDaum
et al. (1982) [23] and has been previously described [24]. The crude
mitochondrial pellet was carefully re-suspended in homogeniza-
tion buffer (10 mM Tris-HCl pH7.4, 0.6 M mannitol, 0.1% bovine
serum albumin and 1 mM PMSF) and centrifuged for 5 min at
1,000g to remove any residual cell debris. The supernatant was
centrifuged at 8,000g for 10 min. Mitochondria were stored frozen
in liquid nitrogen.
2.5. SDS-PAGE and western blotting
The protein concentrations were determined using a BCA assay
kit (Sigma-Aldrich®, St. Louis, MO, USA) using bovine serum albu-
min (BSA) as a standard. Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) was performed on a 15% poly-
acrylamide running gel [25], and resolved proteinwas visualized by
staining with Coomassie Brilliant Blue R250 or by silver staining
[26]. Antibodies directed against SDS-treated-ScVDAC (a-ScVDAC1)were used at a 1/1000 ﬁnal dilution. Immunodetection was per-
formed using horseradish peroxidase (HRP)-coupled protein A and
the enhanced chemiluminescence (ECL) system (Amersham Bio-
sciences®, GE, Healthcare Europe, Glattbrugg, Switzerland).2.6. UV-VIS absorbance spectra
The presence of ergosterol was assessed by UV-VIS absorption
spectra analysis from each collected fraction of puriﬁed ScVDAC1
(Shimadzu® 1605 Spectrophotometer; 200e350 nm scan range).
For data acquisition, experiments utilized a microcomputer and
Suprazil® quartz cell from Hellma® (Plainview, NY, USA).2.7. Negative staining transmission electron microscopy (TEM)
After puriﬁcation, HECAMEG® solubilized ScVDAC1 was adsor-
bed for 10 s to parlodion carbon-coated copper grids (400 mesh)
rendered hydrophilic by glow discharge for approximately 10 s at
low-pressure air. Grids were washed with three drops of double-
distilled water and negatively stained with two drops of 2% (w/v)
uranyl formate. Electron micrographs were recorded at a magniﬁ-
cation of 110,000 on a Morada CCD camera from OLYMPUS. The
Philips CM-12 electron microscope operated at 80-kV acceleration
voltage.
Micrograph of reconstituted protein was taken in same condi-
tions than described up but under Philips CM-10 equipped with a
LaB6 ﬁlament at a magniﬁcation of 94,000 at CiNA (Basel,
Switzerland).2.8. Lipids extraction and thin layer chromatography (TLC)
The lipid extraction protocol presented in this paper is adapted
from Bligh and Dyer [27]. First, 200 ml of ScVDAC puriﬁed at
0.35mg/ml is mixedwith 750 ml of 2:1 (v:v) CHCl3 and ﬁnally 250 ml
of water is added. The sample is centrifuged at 1,000g during
15 min at RT. The upper band of the biphasic phase corresponds to
the soluble hydrophilic part containing than interface where pro-
tein are precipitate and bottom part hydrophobic with lipids.
Lipids were transferred to a glass tube and solvent was evapo-
rated under constant ﬂow N2 gas. Dry lipids were solubilized into
1:9 (v:v) methanol:dichloromethane.
In parallel, silica layer (#1.05724.0001 Silica gel 60, Merck,
Whitehouse station, USA) was dried into Pasteur sterilization
incubator for 45 min at 160 C. 50 nmol of cholesterol (CHO)
(#C8667, Sigma-Aldrich®, St. Louis, MO, USA) was loaded on line 1
and ScVDAC lipid extract on line 2. Samples were ran in a saturated
chamber containing 1:9 (v:v) methanol:dichloromethane. Iodine
(I2) staining and UV light were used to visualize the presence of
lipid bands.2.9. Micro-dialysis
Reconstituted protein was obtained by dialysis using a home-
built dialysis button (40 ml chamber volume) associated with a
14 kDa MWCOmembrane. Membrane protein solution (1 mg/ml in
0.2% HECAMEG®) and detergent-solubilized lipids (DMPC) at
(10 mg/ml in 2% HECAMEG®) were mixed at lipid-protein ratios of
0.1 (w/w) and incubated on ice for 1 h. The ternary mixture was
dialyzed against a continuously exchanged 1 L buffer containing
10 mM Tris-HCl pH 7.5, 150 mM NaCl, 15 mMMgCl2, 2 mM DTT and
2 mM NaN3. A speciﬁc temperature proﬁle was applied during the
four days of dialysis (two days at 34 C). The resulting vesicles were
evaluated by negative stain transmission electron microscopy.
Fig. 1. (A) Workﬂow of ScVDAC1 puriﬁcation. Mitochondria were isolated from W303 strain and solubilized in detergent. The lysate was loaded on a hydroxyapatite (HA) column.
The protein was eluted by centrifugation or by application of air pressure via a plunger. (B) Detergent structure used for puriﬁcation of ScVDAC1. Detergents are classiﬁed according
to their charge properties. Structural formulas were generated with MarvinView program from ChemAxon Suite where oxygen and nitrogen atoms are colored in red and blue,
respectively.
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The micro-scale thermophoresis (MST) uses infrared sources to
create localized microscopic temperature gradients in a capillary
with a very small volume of 4 ml. The motion of macromolecules
such as proteins in temperature ﬁelds is sensitive to changes in its
size, charge and solvation shell. Based on this biophysical proper-
ties, protein-small molecule interaction can be measured and a
titration can be perform to access to afﬁnity constant (KD) at steady
state. MST is equipped with a ﬂuorescence detector able tomeasure
thermophoresis of labeled proteins in capillaries containing
different concentration of the substrate. This method has been
described in detail elsewhere [28]. KD of ATP was measured using
the Monolith NT.115 from Nanotemper Technologies. ScVDAC1 was
ﬂuorescently labeled according to the manufacturer's protocol us-
ing the L003 Monolith™ Protein Labeling kit RED-NHS (amine
reactive) without or pre-incubation with 10 mM ATP. The labeling
procedure and the subsequent removal of free dye were performed
within 1 h. Solutions of substrates were serially diluted from
50mM to 1.5 mM for ATP in presence of 20 nM labeled ScVDAC1. The
samples were loaded into capillaries (NanoTemper Technologies
GmbH, München, Germany). Measurements were performed at
25 C in 10 mM Tris-HCl pH 7.3, 100 mM Na2SO4 and 0.07%HECAMEG®, by using 85% LED power and 80% IR-laser power using
a NT.115 instrument (NanoTemper Technologies GmbH, München,
Germany). Data analysis was performed using Nanotemper Anal-
ysis software, v.1.2.101 and KaleidaGraph software (Synergy Soft-
ware, PA, USA).
3. Results
3.1. Detergent screening for ScVDAC1 puriﬁcation
The method used to purify non-recombinant ScVDAC1 was
adapted from Brandolin et al. [29] and further developed in this
study. The principle of the method is based on the retention of all
proteins from a mitochondrial lysate on a hydroxyapatite (HA)
column, except ScVDAC1, the mitochondrial ADP/ATP and phos-
phate carriers, which are not being retained given the detergent
structure used. The chemical nature, the combination and the
concentrations of the detergents used to solubilize mitochondrial
membranes are critical parameters [30]. Indeed, the actual method
to purify VDAC is based on using of Triton X-100 as extraction
detergent after HA whereby the ADP/ATP carrier is also co-puriﬁed
in excess (section results on this study and [31]). Interestingly, the
authors show that the combination of HA with Celite
Fig. 2. Screening of detergents for one-step puriﬁcation ScVDAC1. The experiments
were performed as described in paragraph 3.1. Eluates obtained after centrifugation of
the mitochondrial lysate on the HTP column were analyzed by SDS-PAGE (15% acryl-
amide) Coomassie blue staining. Five detergents were tested: LAPAO (lane 2), Anapoe-
C8E4 (lane 3), Anapoe-C10E6 (lane 4), Triton X-100 (lane 1 and 5) and HECAMEG® (lane
6 and 7). The puriﬁed protein was ScVDAC1 as shown by immuno-staining with an
antibody directed against ScVDAC1 (lane 7).
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carrier from eluted fraction. A second step of puriﬁcation was
mandatory to exchange detergent and to concentrate the protein.
Conversely, to prevent co-puriﬁcation of VDAC with ADP/ATP car-
rier, some investigators used alternative protocols with mitoplasts
as a starting material and they employed another detergent, C12E8,
instead of Triton X-100 [32].
In this study, we tried to determine which detergent after HA
allows a one-step puriﬁcation to extract pure VDAC, whereby the
purity was accessed by Coomassie Blue staining after SDS-PAGE.
Freshly thawed mitochondria isolated from the W303 strain were
solubilized at 10 mg.ml1 in the presence of a ﬁnal detergent/
protein ratio of 10:1 (w/w), in lysis buffer composed of 10 mM Tris-
HCl pH 7.3, 100 mM Na2SO4, 1 mM EDTA, 1 mM DFP, and a ‘‘cOm-
plete, mini, EDTA-free’’ antiprotease cocktail (25 tablets
#11836170001, Roche, Basel, Switzerland), according to the man-
ufacturer's instructions. After 10 min of gentle shaking at 4 C, the
solubilized protein was puriﬁed by short centrifugation of the hy-
droxyapatite column (2:1 column volume to lysate volume ratio)
during 1 min at 500g or in few seconds by air pressure of the lysate
on the column with the aid of a plunger (Fig. 1A). The obtained
ﬂow-through fraction was containing the puriﬁed ScVDAC1.
The solubilization assay was performed comparing 5 de-
tergents: Nonionic detergents such as HECAMEG® (glucoside),
Triton-X100 (polyethylene oxide), Anapoe-C10E6 and Anapoe-C8E4
(polyoxyethylene glycol) were used and one zwitterionic detergent,
i.e. LAPAO (3-Laurylamido-N,N0-Dimethylpropyl Amine Oxide)
(Fig. 1B). The analysis of the ﬂow-through fractions based on Coo-
massie Blue staining after SDS-PAGE is shown in Fig. 2. Many pro-
teins co-eluted with VDAC when mitochondria were lyzed with
LAPAO, Triton X-100 or Anapoe-C8E4. Two major proteins where
eluted with Anapoe-C10E6. Pure VDAC1 was obtained only with
HECAMEG® and the identity of the eluted proteinwas conﬁrmed by
immunoblotting (Fig. 2). The ﬁnal decision with regard to the cor-
rect detergent that yields extraction of pure VDAC was made using
a detergent condition screen. In order to extract the maximal
amount of protein necessary for structural analysis with minimal
quantity of detergent that often impairs subsequent biophysicaland biochemical analysis, a further step of optimization was
essential, as describe below.
3.2. Optimization of puriﬁcation
Detergents are necessary to isolate and solubilize MP to facili-
tate the desired studies. In contrast, an excess of detergent is usu-
ally incompatiblewith biophysical approaches and thus needs to be
minimized thoroughly. The detergent to protein ratio is always a
critical parameter during the extraction process in order to solu-
bilize the maximal amount of protein. In our particular afﬁnity
chromatography approach, the sample to column volume ratio is
most critical. Different ratios of column to lysate volume were
screened in order to obtain the highest possible protein concen-
tration. As shown in Fig. 3A, the best results were obtained for a 1:1
ratio using a detergent/protein ratio of 10:1 (w/w). ScVDAC1 was
puriﬁed in this one step protocol at a concentration of
0.35 mgml1. The results revealed that, for a 1:2 ratio, contaminant
proteins were eluted along with ScVDAC1.
Detergents are indispensible to solubilize MPs, but their con-
centration and the detergent to protein ratio is a key parameter
maintaining MP in a close to native state and in keeping it func-
tional. Furthermore, depending on the characteristics of the
detergent, it can concentrate along with the protein during the MP
concentration process and thus become deleterious to the MP.
Therefore, it is desirable to purify ScVDAC1 with a minimal amount
of detergent. Different detergent/protein ratios were evaluated
while keeping a maximum effectiveness of extraction (Fig. 3B). A
1:1 detergent/protein ratio was inefﬁcient in extracting ScVDAC1
from mitochondria after the HA gel. For efﬁcient extraction of
ScVDAC1 the ratios 5:1 and 10:1 were suitable. The best ratio
appeared to be 5:1 as it efﬁciently permits extraction of ScVDAC1
with minimal amount of detergent.
However, the yield for puriﬁcation of ScVDAC1 using this
method was not optimal, primarily due to retention of part of
ScVDAC1 in the HA gel which is proportional to the dead volume of
the column (Fig. 3C). Given a 2:1 ratio of column to lysate volume,
the elution volume obtained after the ﬁrst centrifugation roughly
corresponds to the dead volume of the column (Fraction 1), in
which the concentration of puriﬁed ScVDAC1 was very low. An
additional volume of elution buffer corresponding to that of the
lysate gave rise to elution of the main component of ScVDAC1 in the
ﬂow-through fraction (not shown). As can be seen in Fig. 3C,
ScVDAC1 mainly eluted in the ﬁrst 3 fractions after successive ad-
ditions of the lysis buffer containing 0.7% HECAMEG®, corre-
sponding each time to one ﬁfth of the lysate volume. The ScVDAC1
concentration in fractions 1 to 3 (3/5 of the lysate volume) was
~0.7 mg.ml1.
Taken together, we deﬁned the optimal ratio of column to lysate
volumes and detergent/protein ratio to purify VDAC in one centri-
fugation step, in order to minimize the time of puriﬁcation from
minutes to few seconds. Our main interest was to extract VDAC as
fast as possible from isolated mitochondria, in order to reduce
potential denaturation issues. Interestingly, we observed that, for a
2:1 ratio of column to lysate volumes, the protein was not eluted
after the ﬁrst passage. However, VDAC could be eluted after 3
successive small washing steps, as shown in Fig. 3C. This observa-
tion demonstrates that VDAC in HECAMEG® micelles is not inter-
acting with the HA matrix and, therefore, resides in the dead
volume of the column. Thus, the best conditions for maximal
extraction of VDAC corresponds to a 2:1 ratio of column to lysate
volumes by successive washing steps, resulting in a ﬁnal protein
concentration at approximately 0.7 mg.ml1.
The estimated yield of ScVDAC1 puriﬁcation in HECAMEG® from
a 12-l culture was 15 ml at a concentration of 0.7 mg.ml1. The
Fig. 3. Further improvements of HECAMEG® solubilized of ScVDAC1 puriﬁcation (A) Different ratios of column volume to lysate volume (v/v) were tested. The puriﬁcation was
carried out by centrifugation of the lysate through the HA column, according the protocol described in paragraph 3.1. Protein fractions were analyzed by SDS-PAGE (15% gel) and
Coomassie Blue staining. Pure ScVDAC1 was obtained with a 1:1 ratio (v/v) using a ﬁnal detergent/protein ratio of 10:1 (w/w). (B) Determination of the minimal amount of
HECAMEG® necessary to purify mitochondrial ScVDAC1 by HA chromatography. The experiments were performed with a 1:1 column to lysate volume ratio, as described in A.
Different detergent/protein ratios (w/w) were tested. (C) Optimization of the puriﬁcation protocol of ScVDAC1 HECAMEG® detergent by HA chromatography. 5:1 detergent/protein
ratio (w/w) was chosen (see B) with a 2:1 column to lysate volume ratio (v/v) (see A). Top: Analyses by SDS-PAGE (15% gel) of the eluted fractions followed by Coomassie Brilliant
Blue staining. (1) Centrifugation of the lysate on the HA column, (2) to (9) successive elutions (by centrifugation) from the HA column with a volume of elution buffer corresponding
to one ﬁfth of the lysate volume. The protein was concentrated in 2e4 fractions, with a protein concentration of 0.7 mg/ml. Bottom: Absorption spectra the eluted fractions of the
column of HA showing the presence of ergosterol.
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Ultra-15 Centrifugal ﬁlter unit (30 K) (Merck Millipore) and stored
at 20 C for up to two months.
Previous puriﬁcation of VDAC particularly from Neurospora
crassa revealed, based on UV absorption spectroscopy, the presence
of ergosterol [33]. Given this ﬁnding, we decided to analyze all of
the eluted fractions, in order to access ScVDAC purity, as described
below.3.3. Characterization of the ScVDAC1 fractions
To monitor the purity of the eluate, an absorption spectrumwasdetermined for each eluted fraction (Fig. 3C). Although a protein
absorption peak at 280 nm was not observed, interestingly, we
detected a characteristic absorption peak for ergosterol [33,34].
According to SDS-PAGE, following Coomassie Blue staining, the
absorbance of the different peaks increased in proportion to the
amount of puriﬁed ScVDAC1 (Fig. 3C). Ergosterol is present together
with the ADP/ATP carrier in the HA ﬂow-through fraction, when
mitochondria are lyzed with Emulphogen, but it is absent when
lyzed in DDM [34,36]. Therefore, ergosterol binding is not a unique
feature of ScVDAC1. Ergosterol is present in all yeast and fungus
membranes and it may be solubilized by numerous detergents.
However, as seen for the ADP/ATP carrier, ergosterol does not
Fig. 4. Associated VDAC-lipids and reconstitution (A). Thin Layer Chromatography (TLC) of lipids extract from ScVDAC puriﬁed visualized after iodine staining and UV exposure. (B)
Micrograph of reconstitute ScVDAC in liposomes after negative staining. The ScVDAC is incorporated into endogenous lipids as well as into supplemented DMPC.
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tivity, because ergosterol is a natural and reasonably abundant
component of OMM [34e36]. The presence of ergosterol was
conﬁrmed from lipids extracted from the ScVDAC1 eluted fraction
by separation and subsequent analysis using thin layer chroma-
tography (TLC), following iodine staining and UV-detection, with
cholesterol (CHO) as a marker (Fig. 4A). For TLC, CHO was used as
structural analogues of ergosterol which has the same migration
propriety, but, in contrast to ergosterol, exhibits no ﬂuorescence
under UV light. The TLC of ScVDAC sample revealed the presence of
lipids other than ergosterol, which are more polar and possibly
correspond to phospholipids. The observed upper band, which is
also ﬂuorescent, may correspond to an aggregate of ergosterol.
In order to demonstrate the high amount of endogenous cop-
uriﬁed lipid with our protein preparation, we tried to reconstitute
ScVDAC into liposome without addition of lipids. Indeed, complete
reconstitution of ScVDAC as proteoliposomes was observed, when
using a very low lipid to protein ratio (LPR) of 0.1, using DMPC, as
shown by TEM, following negative staining (Fig. 4B).3.4. Supramolecular assembly of puriﬁed ScVDAC1
Usually, membrane protein function depends highly on the
proper supramolecular and oligomeric assembly, in order to war-
rant full cellular activity. According to the literature, this also holds
true for VDAC. Thus, we employed TEM, following negative staining
of puriﬁed and solubilized ScVDAC, to access its oligomeric state.
The oligomeric state was assessed by TEMwith sufﬁcient resolution
to distinguish the supramolecular assembly, following the proce-
dure of Dolder et al. [37]. The level of oligomerization is an
important indicator of the correct native state of membrane pro-
teins such as ScVDAC1 [38] and it needs to be carefully considered
before undertaking structural studies.
TEM experiments require low concentrations of proteins
(~15 mg.ml1). Therefore, we diluted the puriﬁed VDAC sample to
the appropriate concentration after one HA chromatography pas-
sage (Fig. 3C). The eluate was further analyzed by SDS-PAGE (15%gel), followed by silver staining. As shown in Fig. 5A, ScVDAC1
migrated as one band at 31 kDa, but a contaminant band of
approximately 14e15 kDawas also detected. Nonetheless, since the
molecular weight of this contaminant is much lower than that of
ScVDAC1, it was expected not to interfere with TEM analysis.
As shown in Fig. 5B, ScVDAC1 was nicely solubilized without
aggregation and it was mainly present in the form of monomers,
dimers, and trimers which correspond to the previously reported
functional states, although higher oligomeric states were also
visible but to a much lower extent. Close-ups of the monomers,
dimers and trimers are shown in Fig. 5C. Each monomer contains
one round-shaped pore, independent of the degree of the oligo-
merization state. Different oligomerization states were also re-
ported for ScVDAC1 based on atomic force microscopy [39],
although we did not observe oligomerization degrees as high as
those reported these investigators. Our results conﬁrm data ob-
tained by cross-linking experiments, which demonstrated naturally
occurring dimers and trimers of VDAC [40] and also higher degrees
of oligomerization [41]. The monomers are similar to the ones
observed by Dolder et al. [37].
TEM analysis of puriﬁed fractions veriﬁed the conserved native
oligomeric state of ScVDAC after extraction. In other words, the
detergent is able to extract the protein from the lipid bilayer
without disrupting its oligomeric states. The next step was to
determine whether the puriﬁed ScVDAC solubilized using our
conditions with HECAMEG® as detergent was still functional. One
of the principal critiques of Colombini concerns the property of the
puriﬁed VDAC used for crystallizationwhich turned out not to be in
a functional state. Indeed, even if the proteinwas reconstituted into
liposomes for electrophysiological measurements, the conditions
used were different from puriﬁed protein and they did not repre-
sent the overall property of the sample used for crystallization. In
our studies, we preferred to determine the integrity of the channel
directly in the puriﬁed fraction that was used for structural analysis
and also, we did not focus on electrophysiological measurements
for the following reason. In recent years, VDAC was found to be a
rather selective channel particularly for ATP, rather than a simple,
Fig. 5. TEM analyses of puriﬁed ScVDAC1. (A) SDS-PAGE (13% gel) of puriﬁed ScVDAC1 used for this study in silver staining. A 15 kDa-contaminant band is visible. (B) Micrograph
obtained by TEM after negative staining of ScVDAC1 solubilized in HECAMEG® reveals the presence of oligomers in the preparation. The scale bar is 300 nm. (C) Organization of
ScVDAC1 solubilized in HECAMEG®. Oligomers were manually classiﬁed using EMAN2 software (box size: 64  64 pixels). The various oligomeric states derived from the same
micrograph were zoomed and classiﬁed in a gallery of images. Ten monomers, several dimers, three trimers and ﬁve higher oligomers are labeled.
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protein was misfolded and therefore was not able to bind to its
natural substrate, we decide to use micro-scale thermophoresis
(MST) to assess binding to ATP.3.5. Measurements of ATP binding on ScVDAC1 solubilized in
HECAMEG® by MST
Following membrane protein puriﬁcation, determination of the
speciﬁc substrate afﬁnity of isolated protein to its ligand provides a
direct molecular indication of the functional state and structural
integrity of the puriﬁed protein. We decide to use a recently
improved MST technique that is based on the migration proprieties
of macromolecules in solution. In this technique, the property of
the protein of interest is directly related to its hydration shell, the
conformational changes and the increase in size induced by speciﬁc
binding of substrates. ScVDAC labeling with dye was necessary in
order to measure the displacement from the detector with
increasing concentration of ATP from 1.5 mM to 50 mM. “Standard”,
“hydrophilic”, “hydrophobic” and “premium” capillaries types weretested before titration to avoid potential aggregation of the protein
due to thematrix support. The “premium” capillaries where surface
is covalently coated with a dense brush of a specially designed
polymer were selected for our study. We unequivocally show
binding of ATP to solubilized ScVDAC1 by MST. The KD (ATP)
measured corresponds to 1.2 mM ± 155 mM with R2 ¼ 0.97 using
four-parameter logistic nonlinear regression curve ﬁtting (Fig. 6A).
To address the question of whether the protocol using the Nano-
temper labeling kit may result in unwanted reactivity with amine
groups of the protein that could affect KD measurements, we pre-
incubated VDAC with 10 mM ATP before labeling, in order to
saturate and protect the ATP binding site(s) exposed during the
procedure. Excessive reactive molecules and ATP were then
removed using the standard gel ﬁltration protocol from the kit and
measurements were performed as described in material and
methods. The KD measured was 2.5 mM ± 642 mM with R2 ¼ 0.96.
This experiment conﬁrms our previous data showing that the KD of
VDAC for ATP is within the millimolar range.
Fig. 6. Determination of the dissociation constant (KD) for ATP of ScVDAC1, as
measured by MST. (A) ATP (1.5 mMe50 mM) was titrated into a ﬁxed concentration of
labeled ScVDAC1 (20 nM). (B) ATP (1.5 mMe50 mM) was titrated into a ﬁxed con-
centration of labeled ScVDAC1 (20 nM) saturated with 10 mM ATP. In both experiment,
thermophoresis is represented as normalized ﬂuorescence (F Norm), multiplied by
1000, yielding a relative ﬂuorescence change per thousand [‰]. The recording was
performed at 20 C using the red LED at 85% and the IR-laser at 80% of maximal power
on the device. The results show the isotherm derived from the raw data and it was
ﬁtted according to the law of mass action to yield an apparent KD (1.2 mM ± 155 mM)
and (2.5 mM ± 642 mM) pre-incubated with ATP.
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The nature of the physiologically relevant, native structure of
VDAC is still a puzzle, despite excellent progress through numerous
NMR and high-resolution crystallographic structure de-
terminations. Both of these structural approaches utilized non-
functional recombinant and overexpressed protein from bacteria
that was extracted from inclusion bodies, and thus these structures
appear to correspond to VDAC refolded into a non-native state as
described by Colombini.
The immediate goal of our study was therefore to implement asimple, fast and efﬁcient puriﬁcation protocol to isolate pure and
functional, non-recombinant ScVDAC1 for structural studies. We
estimate that this progress will be the key to the future high-
resolution structural determinations of VDAC in its native func-
tional state.
The herein reported approach for ScVDAC1 isolation is based on
a simple puriﬁcation procedure. Brieﬂy, ScVDAC was puriﬁed from
mitochondria by either centrifugation or application of air pressure
to an HA column. This procedure assured maximal puriﬁcation
yields and minimized puriﬁcation time, with least number of pu-
riﬁcation steps. Thus, the procedure is elegant, as most puriﬁcation
protocols require more than one step to achieve the desired level of
purity. Unlike TEM which does not require high concentrations of
puriﬁed protein, crystallography studies are more demanding in
this regard. Based on our procedure, we were able to obtain pure
ScVDAC1 at concentration ranges 0.7 to 3e5 mg/ml, thus making
our protocol suitable for both types of structural studies.
Regardless of the approach used, the puriﬁcation of MPs inevi-
tably starts with extraction and solubilization using amphipathic
molecules known as detergents. Efﬁcient extraction of integral
membrane proteins requires both the selection of the appropriate
detergent and the use of suitable solubilization conditions to pre-
serve the activity of the MP. The choice of the detergent is un-
doubtedly of crucial nature because it has a direct impact on the
structure and activity of the protein. In our case, HECAMEG®was an
effective detergent, capable of extracting and solubilizing ScVDAC1
while preserving its native oligomeric states observed in the
membrane and its ability to bind substrates, as demonstrated by
the measurement of KD for ATP. Interestingly, we noticed that
anapoe-C8E4 with an 8C-aliphatic chain can also purify VDAC, but
with less efﬁciency (Fig. 2B) compared to HECAMEG® which has
7C-aliphatic chain (Fig. 1B). Based on these observations, it appears
that for puriﬁcation of these ScVDAC1, it is necessary to use a
detergent with a small aliphatic chain.
Our results conﬁrm the supramolecular assembly of ScVDAC1
observed previously by AFM studies [39]. Moreover, we were able
to measure for the ﬁrst time the KD of ATP and reveal a value in the
mM range from isolated ScVDAC1. Interestingly, unique binding
was observed with an afﬁnity constant ~ 1e2 mM, which makes
sense, knowing that the ATP concentration inside the cell is typi-
cally 1e10 mM [42]. Indeed, VDAC is expected to work as a channel
with lowafﬁnity (KD in themM range) and high capacity. This result
is distinct from that of earlier studies [43], which suggested that
there might be high and low afﬁnity-binding sites within the
micromolar range, similar to the ADP/ATP carrier.
Ergosterol was found to be associated with pure ScVDAC1. This
steroid is the biological precursor of vitamin D2 (a vitamin D sup-
plement, also known as ergocalciferol). Ergosterol is a component
of yeast and fungal cell membranes and does not occur in plant or
mammalian cells. It is considered as an equivalent of cholesterol in
higher eukaryotes. This lipid likely facilitates insertion of ScVDAC1
into artiﬁcial membranes which is important for electron crystal-
lography of two-dimensional crystals using cryo-electron
microscopy.
In conclusion, our ScVDAC1 puriﬁcation protocol is efﬁcient and
appears appropriate for future structural and functional studies
because the puriﬁed ScVDAC1 exhibits the properties of its native
functional conformation and oligomeric state.
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